prascend 1 mg tablets for horses
boehringer ingelheim ltd - pergolide mesilate - tablet - 1 milligram(s) - pergolide - non food-producing horses - neurological preparations
pergolide teva ® 0.25 mg
teva pharmaceutical indust.ltd - pergolide as mesylate 0.25 mg - tablets - pergolide - pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of parkinson's disease with on-off phenomena. pergolide is indicated as monotherapy in the initial treatment period of parkinson's disease.
pergolide mesylate
ranvet pty. limited - pergolide mesylate - unknown - pergolide mesylate amino active 0.0 - active constituent
pergolide mesylate
boehringer ingelheim animal health australia pty. ltd. - pergolide mesylate - unknown - pergolide mesylate amino active 0.0 - active constituent
prascend 1 mg tabl.
boehringer ingelheim vetmedica gmbh - pergolide mesilate - eq. pergolide 1,31 mg - tablet - 1 mg - pergolide mesilate - paracetamol - horse
ranvet's pergolide
ranvet pty. limited - pergolide mesylate - oral solution/suspension - pergolide mesylate amino active 1.0 mg/5ml - endocrine system - horse | pony | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pace - cushings disease | hyperadrenocortisism | pituitary dependent hyperdreno
prascend 1mg tablets for horses
boehringer ingelheim animal health australia pty. ltd. - pergolide mesylate - oral tablet - pergolide mesylate amino active 1.0 mg/tb - endocrine system
celance 1000 microgram tablets
eli lilly and company limited - pergolide mesilate - tablets - 1000 microgram
celance 50 microgram tablets
eli lilly and company limited - pergolide mesilate - tablets - 50 microgram
celance 250 microgram tablets
eli lilly and company limited - pergolide mesilate - tablets - 250 microgram